Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | CD44 | P16070 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31461336 | 1.00 | MEN1 (0.55) | MEN1KMT2ACD44CYP1A2CYP2A6 | |
| Phosphoric Acid SCHEMBL29008757 | 0.89 | MEN1 (0.46) | MEN1KMT2AALDH1A1 | |
| SCHEMBL28972004 | 0.79 | MEN1 (0.40) | MEN1KMT2ACD44CYP1A2CYP2A6 | |
| SCHEMBL4697734 | 0.79 | MEN1 (0.51) | MEN1KMT2AGAAMAPTMCL1 | |
| SCHEMBL5273065 | 0.79 | MEN1 (0.51) | MEN1KMT2ACYP1A2CYP2A6GAA | |
| SCHEMBL2057766 | 0.79 | MEN1 (0.51) | MEN1KMT2AGAAMAPTMCL1 | |
| SCHEMBL14963003 | 0.79 | MEN1 (0.65) | MEN1KMT2ACYP1A2CYP2A6ALDH1A1 | |
| SCHEMBL28857151 | 0.75 | KMT2A (0.51) | MEN1KMT2ACYP2A6GAAMAPT | |
| SCHEMBL4349057 | 0.75 | MEN1 (0.51) | MEN1KMT2A | |
| SCHEMBL28855115 | 0.74 | KMT2A (0.36) | MEN1KMT2AGAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112940519-B | Light-stable heptamethine cyanine fluorescent dye and synthesis method and application thereof | 中国科学院大连化学物理研究所 | 2023-03-31 | — | — | CN | claimed |
| CN-117447636-A | Photo/mechanochromatic material and preparation method and application thereof | 中国科学技术大学 | 2024-01-26 | — | — | CN | disclosed |
| CN-114441467-B | Dual-mode probe and application thereof | 山东大学 | 2023-06-09 | — | — | CN | disclosed |
| CN-112940519-B | Light-stable heptamethine cyanine fluorescent dye and synthesis method and application thereof | 中国科学院大连化学物理研究所 | 2023-03-31 | — | — | CN | disclosed |
| CN-110041305-A | Half cyanines fluorescence probe of indoles, preparation method and the application in cyanide ion detection | 三峡大学 | 2019-07-23 | — | — | CN | disclosed |
| CN-107629036-A | A kind of fluorescence probe of visual detection copper ion and its preparation method and application | 贺州学院 | 2018-01-26 | — | — | CN | disclosed |
| CN-103044406-B | Coumarin derivatives and preparation method thereof and the application in detection cyanide ion | SHANXI JINHUA STEEL SURFACE TECHNOLOGY RESEARCH INSTITUTE (CN) | 2015-09-16 | — | — | CN | disclosed |
| CN-103251513-A | Dye composition comprising at least one colorless disulfide/thiol precursor, and dyeing process using the composition | OREAL | 2013-08-21 | — | — | CN | disclosed |
| CN-103044406-A | Coumarin derivative and preparation method and application in detecting cyanide ion | SHANXI JINHUA STEEL SURFACE TECHNOLOGY RES INST | 2013-04-17 | — | — | CN | disclosed |
| CN-102702226-A | Preparation of novel spirooxazine compound and photochromic property improvement thereof | HUNAN COLLEGE TRADITIONAL CHINESE MEDICINE | 2012-10-03 | — | — | CN | disclosed |
| US-8034125-B2 | Dye composition comprising at least one colorless disulfide/thiol precursor, and dyeing process using the composition | L'OREAL S.A. (FR) | 2011-10-11 | — | — | US | disclosed |
| EP-2205681-B1 | DYE COMPOSITION COMPRISING AT LEAST ONE COLORLESS DISULFIDE/THIOL PRECURSOR, AND DYEING PROCESS USING THE COMPOSITION | OREAL (FR) | 2011-08-31 | — | — | EP | disclosed |
| US-20110016642-A1 | DYE COMPOSITION COMPRISING AT LEAST ONE COLORLESS DISULFIDE/THIOL PRECURSOR, AND DYEING PROCESS USING THE COMPOSITION | L'OREAL S.A. (FR) | 2011-01-27 | — | — | US | disclosed |
| CN-101802107-A | Dye composition comprising at least one colourless disulfide/thiol precursor and dyeing process using said composition | OREAL | 2010-08-11 | — | — | CN | disclosed |
| EP-2205681-A1 | DYE COMPOSITION COMPRISING AT LEAST ONE COLORLESS DISULFIDE/THIOL PRECURSOR, AND DYEING PROCESS USING THE COMPOSITION | L'Oreal (FR) | 2010-07-14 | — | — | EP | disclosed |
| WO-2009040354-A1 | DYE COMPOSITION COMPRISING AT LEAST ONE COLORLESS DISULFIDE/THIOL PRECURSOR, AND DYEING PROCESS USING THE COMPOSITION | L'OREAL (FR) | 2009-04-02 | — | — | WO | disclosed |
| CN-1148433-C | Photochromic spirooxazine compound bound with moleculae of antioxidizing agent and its preparing process and use | 中国科学院感光化学研究所 | 2004-05-05 | — | — | CN | disclosed |
| CN-1312249-A | Preparation of asymmetric cyanine dyes for DVD-R CD | HUADONG SCIENCE & ENGINEERING (CN) | 2001-09-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110016642-A1 | DYE COMPOSITION COMPRISING AT LEAST ONE COLORLESS DISULFIDE/THIOL PRECURSOR, AND DYEING PROCESS USING THE COMPOSITION | KRT18, SQOR, TST | MEN1 4336/4885KMT2A 2387/4885CD44 495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.